Subcutaneous hepatitis B immune globulin after liver transplantation
โ Scribed by Eric M. Yoshida; Nilu Partovi; Erica D. Greanya
- Book ID
- 112140956
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 684 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.23454
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro
cleoside analogues, 8-10 the only established treatment option Hepatitis B virus (HBV) replicates via an intermediate to prevent reinfection is the administration of polyclonal hep-RNA step. High frequency of polymerase errors with adatitis B surface antigen antibody (anti-HBs) (hepatitis B imdition
"Escape" variants of hepatitis B virus (HBV) can cause infection despite previous immunization. These viruses show alterations of the immunogenic major hydrophilic loop of the HBV small surface protein (s-protein). We studied whether HBV "escape" variants were selected in patients with graft infecti